These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters. Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762 [TBL] [Abstract][Full Text] [Related]
6. Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis. Yaffe D; Vergara-Jaque A; Forrest LR; Schuldiner S Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7390-E7398. PubMed ID: 27821772 [TBL] [Abstract][Full Text] [Related]
7. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. Pifl C; Reither H; Hornykiewicz O Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452 [TBL] [Abstract][Full Text] [Related]
8. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. Biezonski DK; Meyer JS J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520 [TBL] [Abstract][Full Text] [Related]
9. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine. Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842 [TBL] [Abstract][Full Text] [Related]
10. Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action. Kortagere S; Fontana AC; Rose DR; Mortensen OV Neuropharmacology; 2013 Sep; 72():282-90. PubMed ID: 23632081 [TBL] [Abstract][Full Text] [Related]
11. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)]. Verweij AM Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250 [TBL] [Abstract][Full Text] [Related]
12. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines. Montgomery T; Buon C; Eibauer S; Guiry PJ; Keenan AK; McBean GJ Br J Pharmacol; 2007 Dec; 152(7):1121-30. PubMed ID: 17891159 [TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2). Vartak AP; Nickell JR; Chagkutip J; Dwoskin LP; Crooks PA J Med Chem; 2009 Dec; 52(23):7878-82. PubMed ID: 19691331 [TBL] [Abstract][Full Text] [Related]
14. The ins and outs of vesicular monoamine transporters. Yaffe D; Forrest LR; Schuldiner S J Gen Physiol; 2018 May; 150(5):671-682. PubMed ID: 29666153 [TBL] [Abstract][Full Text] [Related]
15. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. Yelin R; Schuldiner S FEBS Lett; 1995 Dec; 377(2):201-7. PubMed ID: 8543051 [TBL] [Abstract][Full Text] [Related]
17. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Verrico CD; Miller GM; Madras BK Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332 [TBL] [Abstract][Full Text] [Related]
18. Chronic and acute effects of 3,4-methylenedioxy-N-methylamphetamine ('Ecstasy') administration on the dynorphinergic system in the rat brain. Di Benedetto M; D'addario C; Candeletti S; Romualdi P Neuroscience; 2006; 137(1):187-96. PubMed ID: 16289352 [TBL] [Abstract][Full Text] [Related]
19. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe. Gopalakrishnan A; Sievert M; Ruoho AE Mol Pharmacol; 2007 Dec; 72(6):1567-75. PubMed ID: 17766642 [TBL] [Abstract][Full Text] [Related]
20. Vesicular monoamine transporter 2: role as a novel target for drug development. Zheng G; Dwoskin LP; Crooks PA AAPS J; 2006 Nov; 8(4):E682-92. PubMed ID: 17233532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]